Stock-based Compensation (Tables)

12 Months Ended

Dec. 31, 2024

Share-Based Payment Arrangement [Abstract]

Fair Value Assumptions for Stock Options

The following are the weighted-average assumptions used to calculate the grant-date fair values of stock option and SARs awards granted in the years ended December 31, 2024, 2023 and 2022:

	For the Years Ended December 31
	2024	2023	2022
Expected dividend yield	1.22%	1.19%	1.18%
Expected volatility	30.89%	31.29%	32.27%
Expected term	6.8 years	7.2 years	6.0 years
Risk-free interest rate	4.23%	4.03%	1.93%

Summary of Stock Option Activity

A summary of stock option activity for the year ended December 31, 2024 is presented below:

	Shares			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term		Aggregate Intrinsic Value ($000)
Options
Outstanding at January 1, 2024		368,139		$	86.03
Granted		3,356			87.50
Exercised		(26,735	)		42.42
Forfeited		(6,408	)		101.29
Outstanding at December 31, 2024		338,352			89.21		4.03	$	—
Vested or expected to vest at December 31, 2024		338,352			89.21		4.03		—
Exercisable at December 31, 2024		333,145			89.12		3.96		—

Summary of Stock Award Activity

A summary of stock award activity for the year ended December 31, 2024, is presented below:

	Shares			Weighted-Average Grant Date Fair Value
Stock Awards
Unvested at January 1, 2024		66,786		$	106.00
Granted		140,493			78.97
Vested		(46,205	)		105.52
Forfeited/modified due to change of assumptions		(86,269	)		85.56
Unvested at December 31, 2024		74,805			79.09

Summary of SARs Activity

The following is a summary of SARs activity for the year ended December 31, 2024:

	Shares			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term		Aggregate Intrinsic Value ($000)
SARs
Outstanding at January 1, 2024		831,919		$	96.11
Granted		108,770			90.24
Exercised		(22,852	)		47.77
Forfeited		(72,818	)		100.83
Outstanding at December 31, 2024		845,019			96.26		5.34	$	—